Sikiric, P., et al., A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine
Langan, R
P = 2.40e-03), and RANTES (r = 0.3805
The findings showed that rabbits treated with AOD9604 demonstrated improved joint outcomes compared to control animals, with less morphological and histopathological cartilage damage
Missing a dose should be managed by taking it as soon as remembered, unless its near the next dose time
Long-Term Consequences of Repeated Excess Dosing Some patients intentionally run BPC-157 at doses above published protocols, reasoning that more peptide will accelerate healing